Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Antibiotic
  3. Skin and soft tissue infections
  4. Infections of diabetes-related foot ulcers
  5. Empirical therapy for moderate infection of diabetes-related foot ulcers
  6. Intravenous therapy for moderate infection of diabetes-related foot ulcers
  7. Patients at increased risk of MRSA infection
  • Antibiotic
    • Bartonella infections
    • Osteomyelitis
    • Septic arthritis of a native joint
    • Bone and joint infections other than osteomyelitis and native joint septic arthritis
    • Sepsis or septic shock associated with a bone or joint source
    • Directed therapy for native bone or joint infection
    • Brucellosis
    • Infective endocarditis
    • Cardiovascular system infections other than endocarditis
    • Central nervous system infections
    • Coronavirus disease 2019 (COVID-19)
    • Cryptococcosis
    • Cytomegalovirus (CMV) infection
    • Infectious diarrhoea
    • Ear, nose and throat infections
    • Eye infections
    • Febrile neutropenia
    • Genital and sexually transmissible infections
    • Human immunodeficiency virus
    • Intra-abdominal infections
    • Leptospirosis
    • Lyme disease
    • Mediastinitis
    • Melioidosis
    • Mpox (monkeypox)
    • Nocardiosis
    • Nontuberculous mycobacterial infections
    • Oesophageal infections
    • Parasitic infections
    • Perinatal infections
    • Prevention of infection
    • Q fever
    • Pneumonia
    • Directed therapy for pneumonia
    • Respiratory tract infections other than pneumonia
    • Acute rheumatic fever
    • Rickettsial infections
    • Salivary gland infections
    • Sepsis and septic shock: Identification and initial management
    • Sepsis and septic shock: Empirical regimens
    • Directed therapy for bloodstream infections, including sepsis and septic shock
    • Skin and soft tissue infections
      • Boils and carbuncles
      • Cellulitis and erysipelas
      • Chickenpox (varicella)
      • Infections of chronic ulcers and wounds
      • Infections of diabetes-related foot ulcers
        • Assessing diabetes-related foot ulcers for infection
        • Approach to managing infection of diabetes-related foot ulcers
        • Empirical therapy for mild infection of diabetes-related foot ulcers
        • Empirical therapy for moderate infection of diabetes-related foot ulcers
          • Antibiotic choice for moderate infection of diabetes-related foot ulcers
          • Oral therapy for moderate infection of diabetes-related foot ulcers
          • Intravenous therapy for moderate infection of diabetes-related foot ulcers
            • Patients at low risk of MRSA infection
            • Patients at increased risk of MRSA infection
            • Modification of intravenous therapy for moderate infection of diabetes-related foot ulcers
        • Empirical therapy for severe infection of diabetes-related foot ulcers
        • Duration of antibiotic therapy for infection of diabetes-related foot ulcers
        • References
      • Impetigo
      • Lactational mastitis
      • Necrotising skin and soft tissue infections
      • Recurrent staphylococcal skin infection
      • Shingles (herpes zoster)
      • Staphylococcal scalded skin syndrome
      • Surgical site infections
    • Traumatic wound infections
    • Urinary tract infections in adults
    • Urinary tract infections in children
    • Identifying resistant pathogens or Candida species
    • Principles of obtaining blood for culture
    • Principles of antimicrobial use
    • Antimicrobial stewardship (AMS)
    • Practical information on using antimicrobial drugs
    • Aminoglycoside use
    • Vancomycin use in adults
    • Vancomycin use in young infants and children
    • Monitoring antimicrobial blood concentrations
    • Ambulatory antimicrobial therapy
    • Antimicrobial hypersensitivity
    • Kidney impairment and antimicrobial dosing
    • Contact details for health departments and public health units
    • Amikacin initial dose calculator
    • Gentamicin initial dose calculator
    • Tobramycin initial dose calculator

Patients at increased risk of MRSA infection

For patients with moderate infection of a diabetes-related foot ulcer who require intravenous therapy and are at increased risk of MRSA infection, use intravenous ciprofloxacin plus clindamycin, as for severe infection.

  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)